New partnership in Iberia

We are happy to announce a new partnership with DTA,S.L. in Iberia. Through the agreement, the Madrid-based company assumes responsibility for the distribution of MVision’s segmentation services in Spain and Portugal.

“We are very excited to work with MVision as their product fits perfectly to our mission of making the most innovative solutions to improve the quality of radiation therapy treatments available to our clients”, says Roberto Casado, the managing director and owner of DTA,S.L.. Mahmudul Hasan, the founder and CEO of MVision, is excited about the collaboration as well: “I am very happy to see DTA join our global partner network and look forward to making our products more available in the region.”

For more information, please contact pr@mvision.ai.

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

24.10.2024

MVision AI Secures FDA 510(k) Clearance for Contour+ Advanced CT and MR Models

Helsinki, October 2024 – MVision AI, a leading innovator in AI-powered solutions for radiotherapy, is thrilled to announce that its auto-contouring solution Contour+ has received FDA 510(k) clearance for three new models: Bones CT, Brain MR, and Male Pelvis MR T2, and five updated models: Brain CT, Abdomen & Lung…

Press Releases

22.10.2024

Saving Time to Improve Workflow and Patient Comfort: A New AI-Based Solution for Gynaecological Brachytherapy

Navigating Discomfort Radiation therapy is a non-invasive and non-painful cancer treatment. However, some patients might experience mild discomfort during treatment sessions, determined by a variety of factors. Physical discomfort due to positioning and immobilisation represent one of the most common causes [1]. Despite the medical team’s efforts, keeping the same…

Articles

11.10.2024

Baylor College of Medicine and MVision AI Collaborate to Drive AI-Powered Innovations in Radiation Therapy

Helsinki, Finland, October 11, 2024 – Baylor College of Medicine and MVision AI have entered into a strategic research and development agreement to drive innovation in radiation therapy through AI technology. This collaboration aims to accelerate the clinical adoption of AI-powered solutions, enhancing the efficiency and effectiveness of cancer treatment.…

Press Releases